Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.40
-0.60 (-2.00%)
Apr 29, 2026, 1:54 PM CST
62.88%
Market Cap 2.16B
Revenue (ttm) 708.38M
Net Income (ttm) -39.43M
Shares Out 72.45M
EPS (ttm) -0.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 594,676
Average Volume 1,085,338
Open 30.00
Previous Close 30.00
Day's Range 28.55 - 30.05
52-Week Range 17.70 - 36.85
Beta 0.05
RSI 52.95
Earnings Date Apr 30, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2025, Genomics BioSci & Tech.'s revenue was 708.38 million, an increase of 36.86% compared to the previous year's 517.58 million. Losses were -39.43 million, -82.33% less than in 2024.

Financial Statements

News

There is no news available yet.